The trading price of Immunome Inc (NASDAQ:IMNM) floating lower at last check on Monday, April 01, closing at $22.41, -9.20% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $30.96 and a 52-week low of $4.44. Over the past month, the stock has lost -7.40% in value.
Immunome Inc, whose market valuation is $1.25 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.73 per share this quarter, however they have predicted annual earnings per share of -$1.49 for 2024 and -$1.69 for 2025. It means analysts are expecting annual earnings per share growth of 72.30% this year and -13.40% next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $5.47 million. The company’s revenue is forecast to drop by -61.00% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Immunome Inc 1 upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest IMNM has a 50% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Buy, while an average of long term indicators suggests that the stock is currently 100% Buy.
A quick review shows that IMNM’s price is currently -8.65% off the SMA20 and 1.55% off the SMA50. The RSI metric on the 14-day chart is currently showing 45.11, and weekly volatility stands at 7.28%. When measured over the past 30 days, the indicator reaches 7.96%. Immunome Inc (NASDAQ:IMNM)’s beta value is currently sitting at 1.66, while the Average True Range indicator is currently displaying 1.98.
To see how Immunome Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: IMNM stock’s performance was -9.20% at last check in today’s session, and 348.20% in the past year.
An evaluation of the daily trading volume of Immunome Inc (NASDAQ:IMNM) indicates that the 3-month average is 697.48K. However, this figure has increased over the past 10 days to an average of 0.56 million.
Currently, records show that 55.67 million of the company’s shares remain outstanding. The insiders hold 19.07% of outstanding shares, whereas institutions hold 38.41%. The stats also highlight that short interest as of Mar 15, 2024, stood at 3.01 million shares, resulting in a short ratio of 4.03 at that time. From this, we can conclude that short interest is 5.26% of the company’s total outstanding shares. It is noteworthy that short shares in March were down slightly from the previous month’s figure, which was 3.85 million. However, since the stock’s price has seen 109.44% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
